Watch Chantal Mathieu and Emanuele Bosi exchanging their expert perspectives on

  • the updated staging criteria for presymptomatic type 1 diabetes
  • emerging therapies to delay disease progression
  • why and how to screen children from the general population, decoding the new Consensus Monitoring Guidance for Monitoring Individuals with Islet Autoantibody-Positive Pre-Stage Type 1 Diabetes.

Find out where to screen a child in Europe on EDENT1FI.EU – the European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception. The network brings together academics, industry and patient organisations, and aims „to arrest type 1 diabetes at the pre-clinical phase“. For that, 200,000 children across Europe are to be assessed in the coming years.

Experts

  • EASD president Prof. Chantal Mathieu, University of Leuven
  • Prof. Emanuele Bosi, Università Vita-Salute San Raffaele, Milan

References

  • Phillip M, Achenbach P, Addala A, et al. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetologia (2024). https://doi.org/10.1007/s00125-024-06205-5
  • Hummel S, Carl J, Friedl N, Winkler C, et al.; Fr1da Study Group. Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation. Diabetologia. 2023 Sep;66(9):1633-1642. doi: 10.1007/s00125-023-05953-0